12/17
02:34 am
orxoy
Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology [Yahoo! Finance]
Neutral
Report
Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology [Yahoo! Finance]
12/17
02:31 am
orxoy
Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology
Neutral
Report
Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology
12/17
02:28 am
orxoy
Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology
Neutral
Report
Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology
10/25
09:28 am
orxoy
Orexo initiates new study of OX640 in participants with allergic rhinitis [Yahoo! Finance]
Neutral
Report
Orexo initiates new study of OX640 in participants with allergic rhinitis [Yahoo! Finance]
10/25
09:28 am
orxoy
Orexo initiates new study of OX640 in participants with allergic rhinitis
Neutral
Report
Orexo initiates new study of OX640 in participants with allergic rhinitis
10/25
09:21 am
orxoy
Orexo initiates new study of OX640 in participants with allergic rhinitis
Neutral
Report
Orexo initiates new study of OX640 in participants with allergic rhinitis
10/24
04:43 am
orxoy
Orexo AB reports Q3 results [Seeking Alpha]
Neutral
Report
Orexo AB reports Q3 results [Seeking Alpha]
10/24
03:34 am
orxoy
Orexo Interim Report Q3 2024 [Yahoo! Finance]
Neutral
Report
Orexo Interim Report Q3 2024 [Yahoo! Finance]
10/24
03:34 am
orxoy
Orexo Interim Report Q3 2024
Neutral
Report
Orexo Interim Report Q3 2024
10/24
03:28 am
orxoy
Orexo Interim Report Q3 2024
Neutral
Report
Orexo Interim Report Q3 2024